,,iv #aae? ,,congress #a/ ,session ,h4 ,,res4 #eic ,,9 ,,! ,,h\se ,,( ,,repres5tatives ,octob] #bf1 #bjag,ms4 ,lee 7= h]self1 ,ms4 ,ros-,leht951 ,ms4 ,norton1 ,mr4 ,evans1 ,mr4 ,coh51 ,ms4 ,b>ragn1 ,ms4 ,mc,collum1 ,mr4 ,nadl]1 ,mr4 ,khanna1 ,mr4 ,mc,govern1 ,ms4 ,max9e ,wat]s ( ,cali=nia1 ,ms4 ,e/y ( ,connecticut1 ,ms4 ,bordallo1 ,mr4 ,lewis ( ,georgia1 ,mr4 ,co/ello ( ,p5nsylvania1 ,mr4 ,s]rano1 ,mr4 ,rodney ,davis ( ,ill9ois1 ,mr4 ,quigley1 & ,ms4 ,judy ,*u ( ,cali=nia7 submitt$ ! foll[+ resolution2 :i* 0 ref]r$ to ! ,committee on ,=eign ,affairs1 & 9 addition to ! ,committee on ,en]gy & ,comm]ce1 = a p]iod to be subsequ5tly det]m9$ by ! ,speak]1 9 ea* case = consid]ation ( su* provisions z fall )9 ! jurisdiction ( ! committee conc]n$ ,,resolution ,recogniz+ ! importance ( a cont9u$ commitm5t to end+ p$iatric ,,hiv_/,,aids worldwide4 ,:]eas approximately half ( ! #cf1gjj1jjj p liv+ ) ! human immunodefici5cy virus 7,,hiv71 ! pa?og5 t causes ! acquir$ immune defici5cy syndrome 7,,aids71 worldwide are wom5 & #b1ajj1jjj are *ildr5 9 #bjaf2 ,:]eas ,,hiv is a lead+ cause ( dea? among wom5 ( *ildbe>+ age worldwide2 ,:]eas ne>ly #ij p]c5t ( ,,hiv-positive expectant mo!rs 9 ne$ ( ,,hiv s]vices worldwide live 9 sub-,sah>an ,africa2 ,:]eas wom5 ar\nd ! _w rely on ess5tial pre- & po/-natal c>e to provide scre5+ = diseases su* z ,,hiv1 & c>e = _! heal? & ! heal? ( _! infants2 ,:]eas :5 antiretroviral drugs are us$ z prophylaxis1 "m-to-*ild transmission ( ,,hiv c be r$uc$ to less ?an #e p]c5t2 ,:]eas 9 #bjje only #ad p]c5t ( wom5 7 receiv+ prev5tion ( "m-to-*ild transmission s]vices & t numb] 9 #bjaf 0 #gf p]c5t2 ,:]eas s9ce #bjja ! numb] ( *ildr5 born ,,hiv positive has be5 m ?an cut 9 half2 ,:]eas despite increas$ global & ,unit$ ,/ates ef=ts ov] #djj *ildr5 7 born ,,hiv positive ea* day 9 #bjaf2 ,:]eas #ij p]c5t ( *ildr5 liv+ ) ,,hiv are 9 sub-,sah>an ,africa2 ,:]eas 9 #bjaf only #dc p]c5t ( *ildr5 ) ,,hiv 7 receiv+ antiretroviral !rapy1 f> bel[ ! p]c5tage ( adults2 ,:]eas )\t treatm5t half ( all *ildr5 ) ,,hiv w die by _! second bir?day1 & #hj p]c5t by _! fif? bir?day2 ,:]eas #abj1jjj *ildr5 di$ ( ,,aids-relat$ causes 9 #bjaf2 ,:]eas #bb p]c5t ( new infections are 9 "y wom5 ag$ #ae to #bd 9 #bjaf2 ,:]eas 9 sub-,sah>an ,africa1 girls acc\nt = #ge p]c5t ( new annual ,,hiv infections among adolesc5ts2 ,:]eas ,,aids is a lead+ cause ( dea? among adolesc5ts globally2 ,:]eas rese>* ef=ts at ! ,national ,in/itutes ( ,heal? h l$ to extraord9>y break?r\ghs = *ildr5 infect$ ) & at risk = ,,hiv2 ,:]eas ! ,unit$ ,/ates began inve/+ 9 prev5tion ( "m-to-*ild transmission 7,,pmtct7 s]vices 9 #bjjb ) ! ann\ncem5t ( ! ,unit$ ,/ates ,int]national ,"m & ,*ild ,,hiv ,prev5tion ,initiative2 ,:]eas 9 fiscal ye> #bjaf1 ! ,presid5t's ,em]g5cy ,plan = ,,aids ,relief 7,,pepf>7 support$ ,,hiv te/+ & c\nsel+ = m ?an #aa1ejj1jjj pregnant wom5 & s9ce ! program's inception ! provision ( antiretroviral drug prophylaxis to prev5t "m-to-*ild transmission has all[$ ne>ly #b1jjj1jjj babies to be born ,,hiv free2 ,:]eas s9ce #bjjb ! ,global ,fund to ,fight ,,aids1 ,tub]culosis & ,mal>ia support$ programs t provid$ #d1bjj1jjj ,,hiv-positive mo!rs ) antiretroviral drug prophylaxis to prev5t ! transmission ( ,,hiv to _! *ildr52 ,:]eas 9 #bjad ,,pepf> ann\nc$ ! ,accel]at+ ,*ildr5's ,treatm5t ,initiative 7,,act7 t w d\ble ! numb] ( ,,hiv positive *ildr5 on treatm5t ov] #b ye>s 9 #aj high-burd5 c\ntries2 ,:]eas ! ,,pepf> ,,dreams initiative is work+ to r$uce new ,,hiv infections 9 adolesc5t & "y wom5 9 #aj sub-,sah>an c\ntries2 ,:]eas e "m %\ld h ! opportunity to fight = ! life ( h] *ild2 & ,:]eas e *ild & adolesc5t %\ld h access to m$ic9es to lead a long & heal?y life3 ,n[1 !re=e1 be x ,t ! ,h\se ( ,repres5tatives-- 7#a7 recognizes t ! prev5tion ( "m-to-*ild transmission ( ,,hiv is critical to /opp+ ! spread ( ,,hiv worldwide2 7#b7 applauds ! ,unit$ ,/ates lead]%ip on ef=ts to elim9ate new p$iatric ,,hiv infections & to scale-up p$iatric treatm5t ?r\gh programs & rese>*2 7#c7 recognizes t ! fight to elim9ate p$iatric ,,hiv worldwide has be5 a priority area = ! ,unit$ ,/ates 9 _! global ,,aids response = m ?an #ac ye>s & calls on ?is lead]%ip to cont9ue2 7#d7 supports provid+ adolesc5ts & "y wom5 ) ! evid5ce-bas$ approa*es necess>y to prev5t new ,,hiv infections2 7#e7 supports provid+ wom5 & *ildr5 ) ,,hiv c\nsel+ & te/+ s]vices :]e possible1 & scal+ up access to s]vices & m$ic9es t prev5t "m-to-*ild transmission ( ,,hiv & ensure ,,hiv positive mo!rs survive & ?rive2 7#f7 supports scal+ up ( treatm5t = ,,hiv = *ildr5 & adolesc5ts includ+ great] access to m efficaci\s antiretroviral drug regim5s1 age appropriate s]vices1 & support = _! c>egiv]s2 & 7#g7 recommits ! ,unit$ ,/ates to lead ! _w to ! end ( ,,aids1 to elim9ate new p$iatric ,,hiv infections worldwide1 & support wom51 *ildr51 adolesc5ts & families infect$ & affect$ by ,,hiv4